On July 8, Arbutus received around $178 million from Moderna as part of a patent litigation settlement, the company said.

A study on COVID-19 vaccine effectiveness has been published after being blocked from a government health journal.

Updated 2025-2026 formulations of mRNA-1283 and BNT162b2 protect older adults against severe COVID-19 outcomes and medically attended illness.

Smaller doses of COVID-19 booster vaccines can provide long-lasting immunity, helping reduce costs and improve access to ...

As monsoon-related illnesses surge every year, consumers should not assume that every expense will automatically be reimbursed ...

The 2025-2026 SARS-CoV-2 vaccines provided protection against ED/UC visits and hospitalizations among immunocompetent adults.

Learn about the companies that are manufacturing vaccines and what you should know before investing in vaccine stocks.

TAMPA, Fla. — Florida’s Department of Health is meeting in Panama City Beach on Friday to discuss potential changes to the state’s vaccine requirements, a proposal that could significantly alter which ...

Add Yahoo as a preferred source to see more of our stories on Google. CDC’s chief blocked a covid vaccine study. Now it’s in a top medical journal. A covid vaccine study that the CDC's chief halted ...

COVID-19 vaccine boosters not only protect against SARS‑CoV‑2 – the virus behind the most recent pandemic – but may also help protect against some future coronaviruses that risk spreading from animals ...